AIDS

1. LAPADULA G, Bernasconi DP, Bai F, Foca E, et al
   Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances: Results from a randomized controlled trial.
   AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002377.
   

   >> Share

   
   
2. 
   A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India: Erratum.
   AIDS. 2021;35:527.
   

   >> Share

   
   
3. LUO G, Su L, Hu X, Lin YF, et al
   The role of e-commerce platforms in optimizing the HIV care continuum.
   AIDS. 2021;35:521-522.
   

   >> Share

   
   
4. VANCE DE, Brew BJ
   HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
   AIDS. 2021;35:511-513.
   

   >> Share

   
   
5. NYAKATO P, Schomaker M, Sipambo N, Technau KG, et al
   Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa.
   AIDS. 2021 Jan 21. pii: 00002030-900000000-96504.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

6. HARIYANTO TI, Putri C, Frinka P, Louisa J, et al
   Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
   AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0307.
   

   >> Share

   
   
7. DI CARLO D, Falasca F, Palermo E, Mezzaroma I, et al
   Dolutegravir-based regimen for maintenance of viral suppression in people living with HIV: 48-week results in real life setting.
   AIDS Res Hum Retroviruses. 2021 Jan 24. doi: 10.1089/AID.2020.0196.
   

   >> Share

   
   
8. CHAWANA TD, Nhachi CFB, Nathoo K, Ngara B, et al
   Higher tenofovir concentrations in hair are associated with decreases in viral load and not self-reported adherence in HIV-infected adolescents with second line virological treatment failure.
   AIDS Res Hum Retroviruses. 2021 Jan 26. doi: 10.1089/AID.2020.0258.
   

   >> Share

   
   
9. DEVANATHAN AS, Kashuba A
   HIV Persistence in the Spleen: Opportunities for Pharmacologic Intervention.
   AIDS Res Hum Retroviruses. 2021 Jan 26. doi: 10.1089/AID.2020.0266.
   

   >> Share

   
   
10. GALIWANGO RM, Ssuuna C, Kaleebu P, Kigozi G, et al
    Validation of the Asante HIV-1 Rapid Recency(R) Assay for detection of recent HIV-1 infections in Uganda.
    AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0279.
    

    >> Share

    
    

    
    BMC Pediatr

11. BINAGWAHO A, Remera E, Bayingana AU, Gishoma D, et al
    Addressing the mental health needs of children affected by HIV in Rwanda: validation of a rapid depression screening tool for children 7-14 years old.
    BMC Pediatr. 2021;21:59.
    

    >> Share

    
    

    
    Clin Infect Dis

12. ANUGWOM CM, Aby ES, Debes JD
    Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?
    Clin Infect Dis. 2020 Jun 5. pii: 5851928. doi: 10.1093.
    

    >> Share

    
    
13. KIRKEGAARD-KLITBO DM, Thomsen MT, Gelpi M, Bendtsen F, et al
    Hepatic steatosis associated with exposure to elvitegravir and raltegravir.
    Clin Infect Dis. 2021 Jan 25. pii: 6119572. doi: 10.1093.
    

    >> Share

    
    
14. LIU L, Wang L, Zhang H, Ou W, et al
    Changing Epidemiology of HBV and HCV Co-Infection in HIV-Positive Population in China: Results from the Third and Fourth Nationwide Molecular Epidemiologic Surveys.
    Clin Infect Dis. 2021 Jan 27. pii: 6121253. doi: 10.1093.
    

    >> Share

    
    
15. NACHEGA JB, Grimwood A, Mahomed H, Fatti G, et al
    From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
    Clin Infect Dis. 2021;72:327-331.
    

    >> Share

    
    
16. DONG HV, Adamson PC, Nguyen HT, Nguyen TV, et al
    Reply to Laumen et al.
    Clin Infect Dis. 2021;72:364-365.
    

    >> Share

    
    
17. MANION M, Lynn N, Pei L, Hammoud DA, et al
    To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era.
    Clin Infect Dis. 2021;72:315-318.
    

    >> Share

    
    
18. FUNG M, Babik JM
    COVID-19 in Immunocompromised Hosts: What We Know So Far.
    Clin Infect Dis. 2021;72:340-350.
    

    >> Share

    
    
19. BARBEE LA, Soge OO, Khosropour CM, Haglund M, et al
    The Duration of Pharyngeal Gonorrhea: A Natural History Study.
    Clin Infect Dis. 2021 Jan 30. pii: 6123922. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

20. BOOTON RD, Ong JJ, Lee A, Liu A, et al
    Modelling the impact of an HIV testing intervention on HIV transmission among men who have sex with men in China.
    HIV Med. 2021 Jan 28. doi: 10.1111/hiv.13063.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

21. ZHANG L, Abohashem S, Osborne MT, Naddaf N, et al
    Lower Socioeconomic Status Associates with Greater Systemic and Arterial Inflammation in HIV.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95961.
    

    >> Share

    
    
22. CRABLE EL, Blue TR, McKenzie M, Rich JD, et al
    Effect of case management on HIV outcomes for community corrections population: Results of an 18-month randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95960.
    

    >> Share

    
    
23. MUCCINI C, Galli L, Poli A, Chiurlo M, et al
    Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95959.
    

    >> Share

    
    
24. CHEN Y, Gao Y, Zhou Y, Li X, et al
    Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-analysis of Prospective Studies.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95958.
    

    >> Share

    
    
25. GOODRICH S, Siika A, Mwangi A, Nyambura M, et al
    Development, assessment and outcomes of a community-based model of anti-retroviral care in western Kenya through a cluster-randomized control trial.
    J Acquir Immune Defic Syndr. 2021 Jan 21. pii: 00126334-900000000-95957.
    

    >> Share

    
    
26. VAN DER HEIJDEN WA, Wan J, Van de Wijer L, Jaeger M, et al
    Plasmatic coagulation capacity correlates with inflammation and abacavir-use during chronic HIV-infection.
    J Acquir Immune Defic Syndr. 2021 Jan 26. pii: 00126334-900000000-95956.
    

    >> Share

    
    
27. COBURN SB, Shiels M, Silverberg M, Horberg M, et al
    Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95962.
    

    >> Share

    
    
28. ONGOLLY FK, Dolla A, Ngure K, Irungu EM, et al
    "I just decided to stop: " Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95963.
    

    >> Share

    
    
29. BUSZA J, Hensen B, Birdthistle I, Chabata ST, et al
    What's in a name? A mixed method study on how young women who sell sex characterise male partners and their use of condoms.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95964.
    

    >> Share

    
    
30. PAMPATI S, Emrick K, Siegler AJ, Jones J, et al
    Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95953.
    

    >> Share

    
    
31. JOHNSON KA, Chen MJ, Kohn R, Sachdev D, et al
    Acute HIV at the time of initiation of Pre or Post Exposure Prophylaxis: Impact on drug-resistance and clinical outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95954.
    

    >> Share

    
    
32. TIEN-HUAN L, Ismael FC, Suzue S, Rommel B, et al
    Evaluating Nonresponse Weighting Adjustment for the Population-Based HIV Impact Assessments Surveys: On Incorporating Survey Outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95955.
    

    >> Share

    
    

    
    J Clin Oncol

33. OLSZEWSKI AJ, Jakobsen LH, Collins GP, Cwynarski K, et al
    Burkitt Lymphoma International Prognostic Index.
    J Clin Oncol. 2021 Jan 27:JCO2003288. doi: 10.1200/JCO.20.03288.
    

    >> Share

    
    

    
    J Infect Dis

34. EATON EF, Clement ME
    Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
    J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
    

    >> Share

    
    
35. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

36. NASREDDINE R, Florence E, Moutschen M, Yombi JC, et al
    Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26828.
    

    >> Share

    
    

    
    J Pediatr

37. KREBS E, Zhou C, Min JE, Carter C, et al
    Diagnosis of Opioid Use Disorder by Youths assessed in Acute Care Settings in British Columbia, Canada.
    J Pediatr. 2021 Jan 27. pii: S0022-3476(21)00080.
    

    >> Share

    
    

    
    J Virol

38. PUSNIK J, Fischinger S, Dittmer U, Esser S, et al
    Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cells.
    J Virol. 2021 Jan 27. pii: JVI.02097-20. doi: 10.1128/JVI.02097.
    

    >> Share

    
    
39. JANAKA SK, Palumbo AV, Tavakoli-Tameh A, Evans DT, et al
    Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4(+) T Cells.
    J Virol. 2021 Jan 27. pii: JVI.01911-20. doi: 10.1128/JVI.01911.
    

    >> Share

    
    
40. MATSUI H, Shirakawa K, Konishi Y, Hirabayashi S, et al
    CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.
    J Virol. 2021 Jan 27. pii: JVI.02394-20. doi: 10.1128/JVI.02394.
    

    >> Share

    
    

    
    JAMA

41. SLOMSKI A
    Simplified Regimen Expands Options for Dual-Therapy HIV Maintenance.
    JAMA. 2021;325:334.
    

    >> Share

    
    
42. WENG MK, Harris AM, Nelson NP
    Update on Hepatitis A Management.
    JAMA. 2021;325:401.
    

    >> Share

    
    
43. VAN DER GRAAF R, Reis A, Godfrey-Faussett P
    Revised UNAIDS/WHO Ethical Guidance for HIV Prevention Trials.
    JAMA. 2021 Jan 27. pii: 2775959. doi: 10.1001/jama.2021.0258.
    

    >> Share

    
    

    
    Lancet

44. SINGH NS, Ataullahjan A, Ndiaye K, Das JK, et al
    Delivering health interventions to women, children, and adolescents in conflict settings: what have we learned from ten country case studies?
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00132.
    

    >> Share

    
    

    
    Lancet Infect Dis

45. SCRIBA TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, et al
    Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
    Lancet Infect Dis. 2021 Jan 25. pii: S1473-3099(20)30914.
    

    >> Share

    
    

    
    PLoS Comput Biol

46. DORIGATTI E, Schubert B
    Graph-theoretical formulation of the generalized epitope-based vaccine design problem.
    PLoS Comput Biol. 2020;16:e1008237.
    

    >> Share

    
    

    
    PLoS One

47. SORSA A, Kaso M
    Diagnostic performance of GeneXpert in tuberculosis-HIV co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0242205.
    

    >> Share

    
    
48. NJAU B, Damian DJ, Abdullahi L, Boulle A, et al
    The effects of HIV self-testing on the uptake of HIV testing, linkage to antiretroviral treatment and social harms among adults in Africa: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245498.
    

    >> Share

    
    
49. PEPITO VCF, Newton S
    Correction: Determinants of HIV testing among Filipino women: Results from the 2013 Philippine National Demographic and Health Survey.
    PLoS One. 2021;16:e0246013.
    

    >> Share

    
    
50. SIMELANE MS, Vermaak K, Zwane E, Masango S, et al
    Individual and community-level factors associated with lifetime number of sexual partners among women aged 15-49 in Eswatini.
    PLoS One. 2021;16:e0246100.
    

    >> Share

    
    
51. TRIPATHI N
    Does family life education influence attitudes towards sexual and reproductive health matters among unmarried young women in India?
    PLoS One. 2021;16:e0245883.
    

    >> Share

    
    
52. WANG Y, Liang H, Zhang L, Zhang Z, et al
    The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: An observational cohort study.
    PLoS One. 2020;15:e0243773.
    

    >> Share

    
    
53. NABUKEERA S, Kagaayi J, Makumbi FE, Mugerwa H, et al
    Factors associated with virological non-suppression among HIV-positive children receiving antiretroviral therapy at the Joint Clinical Research Centre in Lubowa, Kampala Uganda.
    PLoS One. 2021;16:e0246140.
    

    >> Share

    
    
54. DAS S, Ghosh P, Banerjee S, Pyne S, et al
    Determination of critical community size from an HIV/AIDS model.
    PLoS One. 2021;16:e0244543.
    

    >> Share

    
    
55. MUBIRU F, Castelnuovo B, Reynolds SJ, Kiragga A, et al
    Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?
    PLoS One. 2021;16:e0243552.
    

    >> Share

    
    
56. LUO Z, Ding Y, Yuan J, Tian L, et al
    Predictors of serological cure after penicillin therapy in HIV-negative patients with early syphilis in Shenzhen, China.
    PLoS One. 2021;16:e0245812.
    

    >> Share

    
    
57. 
    Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study.
    PLoS One. 2021;16:e0246489.
    

    >> Share

    
    
58. HLASHWAYO DF, Sigauque B, Noormahomed EV, Afonso SMS, et al
    A systematic review and meta-analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan Africa.
    PLoS One. 2021;16:e0245951.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

59. MURAKOWSKI DK, Barton JP, Peter L, Chandrashekar A, et al
    Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
60. BURTON DR
    A new lease on life for an HIV-neutralizing antibody class and vaccine target.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    

    
    Science

61. RAPPAZZO CG, Tse LV, Kaku CI, Wrapp D, et al
    Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
    Science. 2021 Jan 25. pii: science.abf4830. doi: 10.1126/science.abf4830.
    

    >> Share

    
    

    
    Vaccine

62. MUGO N, Eckert LO, Odero L, Gakuo S, et al
    Antibody responses to prophylactic quadrivalent human papillomavirus vaccine at 48 months among HIV-infected girls and boys ages 9-14 in Kenya, Africa.
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31587.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share